Healthcare Professionals
Protégé™ RX Self-expanding Carotid Stent
Carotid Stenting
Overview
Select the Protégé™ RX self-expanding carotid stent system, in straight or tapered models, for custom fit in the common carotid, or internal carotid arteries, and carotid bifurcation when stenting procedures are indicated. Tantalum GPS™ markers enhance visibility for precise positioning and result confirmation.
Indications
The stent is indicated for treatment of stenoses of the common carotid artery (CCA), internal carotid artery (ICA), and carotid bifurcation.
All indications related to the Protégé™ RX Self-expanding Carotid Stent are not approved globally, please refer to the complete Instructions for Use manual for the indication for Use approved in your geography.
Product Details
Predictable Deployment
- Proprietary EX.P.R.T.™ release technology essentially eliminates premature deployment or jumping.
- Minimal stent shortening.
- Unique anatomically designed tapered stent for better fit in the carotid bifurcation.
- Offers 0.014' rapid exchange catheter with 6 F low crossing profile and flexible atraumatic tip.
- Radiopaque marker on catheter clearly indicates tapered location for precise positioning.
Visible Results
- Tantalum GPS™ markers enhance visibility for precise positioning and result confirmation.
- Cell design produces expansion force that resists compression while providing excellent wall apposition.
- Straight and tapered options for customized fit in carotid vessels.
Manuals and Technical Guides
Instructions for Use
Find this technical manual in the product labeling supplied with each device.
MODEL SPECIFICATIONS
| Reference |
Unconstrained Stent Diameter (mm) |
Unconstrained Stent Length |
Rec. Lumen Size (mm) |
Usable Catheter Length |
Sheath Size (F) |
Guidewire |
|---|---|---|---|---|---|---|
| Straight |
||||||
| SEPX-6-20-135 |
6 |
20 |
4.5-5.5 |
135 |
6 |
0.014 |
| SEPX-6-30-135 |
6 |
30 |
4.5-5.5 |
135 |
6 |
0.014 |
| SEPX-6-40-135 |
6 |
40 |
4.5-5.5 |
135 |
6 |
0.014 |
| SEPX-6-60-135 |
6 |
60 |
4.5-5.5 |
135 |
6 |
0.014 |
| SEPX-7-20-135 |
7 |
20 |
5.5-6.5 |
135 |
6 |
0.014 |
| SEPX-7-30-135 |
7 |
30 |
5.5-6.5 |
135 |
6 |
0.014 |
| SEPX-7-40-135 |
7 |
40 |
5.5-6.5 |
135 |
6 |
0.014 |
| SEPX-7-60-135 |
7 |
60 |
5.5-6.5 |
135 |
6 |
0.014 |
| SEPX-8-20-135 |
8 |
20 |
6.5-7.5 |
135 |
6 |
0.014 |
| SEPX-8-30-135 |
8 |
30 |
6.5-7.5 |
135 |
6 |
0.014 |
| SEPX-8-40-135 |
8 |
40 |
6.5-7.5 |
135 |
6 |
0.014 |
| SEPX-8-60-135 |
8 |
60 |
6.5-7.5 |
135 |
6 |
0.014 |
| SEPX-9-20-135 |
9 |
20 |
7.5-8.5 |
135 |
6 |
0.014 |
| SEPX-9-30-135 |
9 |
30 |
7.5-8.5 |
135 |
6 |
0.014 |
| SEPX-9-40-135 |
9 |
40 |
7.5-8.5 |
135 |
6 |
0.014 |
| SEPX-9-60-135 |
9 |
60 |
7.5-8.5 |
135 |
6 |
0.014 |
| SEPX-10-20-135 |
10 |
20 |
8.5-9.5 |
135 |
6 |
0.014 |
| SEPX-10-30-135 |
10 |
30 |
8.5-9.5 |
135 |
6 |
0.014 |
| SEPX-10-40-135 |
10 |
40 |
8.5-9.5 |
135 |
6 |
0.014 |
| SEPX-10-60-135 |
10 |
60 |
8.5-9.5 |
135 |
6 |
0.014 |
| Tapered |
||||||
| SEPX-8-6-30-135 |
8/6 |
30 |
(6.5-7.5)-(4.5-5.5) |
135 |
6 |
0.014 |
| SEPX-8-6-40-135 |
8/6 |
40 |
(6.5-7.5)-(4.5-5.5) |
135 |
6 |
0.014 |
| SEPX-10-7-30-135 |
10/7 |
30 |
(8.5-9.5)-(5.5-6.5) |
135 |
6 |
0.014 |
| SEPX-10-7-40-135 |
10/7 |
40 |
(8.5-9.5)-(5.5-6.5) |
135 |
6 |
0.014 |
* The safety and efficacy of the Protege™ RX carotid stent system in the carotid indication has not been demonstrated with embolic protection devices other than with the SpiderFX™ embolic protection device. The SpiderFX™ embolic protection device has been demonstrated to be compatible with the Protege RX carotid stent system in bench and animal testing.
The clinical data contained within this document reflects data generated using the Protege GPS™ carotid stent system but has been determined to be applicable to the Protege™ RX carotid stent system in bench and animal testing
† Defined as successful deployment and retrieval of distal protection device, successful stent deployment and final diameter stenosis < 50%.
See product catalog for complete, detailed product information.
